Verve Therapeutics Inc.

NASDAQ: VERV · Real-Time Price · USD
4.65
0.33 (7.64%)
At close: May 16, 2025, 3:59 PM
4.56
-1.94%
After-hours: May 16, 2025, 07:56 PM EDT

Verve Therapeutics Revenue

Verve Therapeutics reported an annual revenue of $32.33M, reflecting a 174.98% growth. For the quarter ending March 31, 2025, Verve Therapeutics generated $32.98M in revenue.
Revenue (ttm)
$32.33M
Revenue Growth
174.98%
Price / Sales Ratio
14.78
Revenue / Employee
$118K
Employees
274
Market Cap
414.52M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.